A large case-control study in Caucasians demonstrated that male patients with NSCLC and the VEGF +405CC+CG genotype had a higher risk of lung adenocarcinoma, while those with the −460T/+405G/936C haplotype had a reduced risk. This evidence concerns the gene VEGFA and lung adenocarcinoma.